New pill for advanced cancers enters first human tests
NCT ID NCT06328439
First seen Mar 26, 2026 · Last updated May 16, 2026 · Updated 10 times
Summary
This early-phase study tests a new oral drug, ANS014004, in about 40 adults with advanced solid tumors that have stopped responding to standard treatments. The main goals are to find a safe dose and check for side effects. Researchers will also look for signs that the drug shrinks tumors, but this is not expected to be a cure.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOCALLY ADVANCED OR METASTATIC SOLID TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Shanghai Chest Hospital
Shanghai, China
Conditions
Explore the condition pages connected to this study.